PB0742 JAK2 V617F Allele Burden and Thrombotic Events in Patients with JAK2 V617F Positive Polycythemia Vera or Essential Thrombocythemia at High Risk of Thrombosis
Sun Hwan Bae, Yung-Huyn Hwang, André Lee, Minsuok Kim
Abstract
Sun Hwan Bae, Yung-Huyn Hwang, André Lee, Minsuok Kim
Abstract
Conclusion(s): This data indicates platelets undergo changes after the first dose of chemotherapy.In order to observe the impact in each cancer type and cancer progression, long term follow up are required.These follow up studies can help understand how platelets can be targeted to improve outcomes and therapies in those patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Conclusion(s): This data indicates platelets undergo changes after the first dose of chemotherapy.In order to observe the impact in each cancer type and cancer progression, long term follow up are required.These follow up studies can help understand how platelets can be targeted to improve outcomes and therapies in those patients.
Key concepts: Essential thrombocythemia, Polycythemia vera, JAK2 V617F, Thrombosis, Medicine, Internal medicine, Allele, Gastroenterology